Gp96 and use thereof in treating amyotrophic lateral sclerosis
AssigneeFoshan Heat Shock Biotech Co., Ltd.
InventorsSongdong Meng, Ying Ju, Xin Li, Yuxiu Xu, Fang Cheng, Zihao Wang
Life of this patent
Estimating the term…
Loading patent…
AssigneeFoshan Heat Shock Biotech Co., Ltd.
InventorsSongdong Meng, Ying Ju, Xin Li, Yuxiu Xu, Fang Cheng, Zihao Wang
Estimating the term…
The present invention relates to the field of disease treatment. In particular, the present invention provides a gp96 protein and use of a gp96 protein-constructed fusion protein in treating amyotrophic lateral sclerosis. In addition, the present invention further relates to a pharmaceutical composition that can be used for treating one or more of the symptoms of amyotrophic lateral sclerosis, comprising the gp96 protein or the gp96 protein-constructed fusion protein of the present invention.
A method for preventing and/or treating amyotrophic lateral sclerosis in a subject, comprising:
(canceled)
(canceled)
A fusion protein, comprising a gp96 protein or variant thereof, and an additional peptide linked to the gp96 protein or variant thereof;
(canceled)
Dependencies are inferred from the claim text.